CROSS-DOMAIN PATTERN
Same drug, multiple disease domains
Sinapic Acid appears in hypotheses across 4 disease domains: Alzheimer, Depression, Epilepsy, Multiple sclerosis. Shared mediators that recur across at least two of those domains: ASC, BDNF.
Aggregated from the catalog. Biological interpretation of any multi-indication mechanism would require independent validation — this is a structural observation only.
ALL HYPOTHESES
Repurposing candidates for Sinapic Acid
Alzheimer 2
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| ASC | MCI | 0.248 | Mid | novel signal | none | |
| ASC | AD | 0.220 | Mid | reproduces known | none |
Depression 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| BDNF | schizophrenia | 0.208 | Mid | novel signal | none |
Epilepsy 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| BDNF | epilepsy | 0.230 | Mid | partial evidence | none |
Multiple sclerosis 1
| Mediator | Outcome | Score | Tier | Lit. status | Trial | |
|---|---|---|---|---|---|---|
| ASC | Multiple Sclerosis | 0.220 | Mid | novel signal | none |
No registered trials found on ClinicalTrials.gov. This could indicate either an unexplored indication or a gap in registry coverage.
Search ClinicalTrials.gov →